Nicholas L. Tilney

Nicholas L. Tilney's AcademicInfluence.com Rankings

Nicholas L. Tilney

Philosophy

#5218

World Rank

#7962

Historical Rank

Logic

#2534

World Rank

#3539

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Nicholas L. Tilney's Degrees

Doctorate Medicine Harvard University

Why Is Nicholas L. Tilney Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nicholas L. Tilney's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cyclosporine: a new immunosuppressive agent for organ transplantation. (1984) (569)
The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. (1997) (528)
Vascular Access for Hemodialysis Patency Rates and Results of Revision (1985) (522)
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. (1987) (512)
Effects of explosive brain death on cytokine activation of peripheral organs in the rat. (1998) (433)
Both alloantigen-dependent and -independent factors influence chronic allograft rejection. (1995) (421)
Brain death and its influence on donor organ quality and outcome after transplantation. (1999) (308)
Sequential System Failure after Rupture of Abdominal Aortic Aneurysms: An Unsolved Problem in Postoperative Care (1973) (296)
Chronic rejection. (1998) (294)
Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. (1997) (281)
Chronic rejection--an undefined conundrum. (1991) (275)
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. (1991) (275)
Patterns of lymphatic drainage in the adult laboratory rat. (1971) (266)
Effects of initial ischemia/reperfusion injury on the transplanted kidney. (1997) (238)
The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. (1997) (233)
Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. (1997) (216)
CYTOKINES, ADHESION MOLECULES, AND THE PATHOGENESIS OF CHRONIC REJECTION OF RAT RENAL ALLOGRAFTS (1993) (215)
Natural History of Major Venous Thrombosis of the Upper Extremity (1970) (211)
Activation of the Heart by Donor Brain Death Accelerates Acute Rejection After Transplantation (2000) (206)
Five Years' Experience in Renal Transplantation with Immunosuppressive Drugs: Survival, Function, Complications, and the Role of Lymphocyte Depletion by Thoracic Duct Fistula (1968) (204)
Accelerated Rejection of Renal Allografts From Brain-Dead Donors (2000) (204)
Activation of inflammatory mediators in rat renal isografts by donor brain death. (2000) (202)
Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. (1995) (199)
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. (1996) (172)
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. (1991) (168)
Long‐Term Kidney Isografts Develop Functional and Morphologic Changes That Mimic Those of Chronic Allograft Rejection (1994) (167)
Identity and cytotoxic capacity of cells infiltrating renal allografts. (1975) (165)
Influence of donor brain death on chronic rejection of renal transplants in rats. (2001) (161)
The Combination of Donor and Recipient Age is Critical in Determining Host Immunoresponsiveness and Renal Transplant Outcome (2010) (157)
Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model. (1992) (137)
Late consequences of acute ischemic injury to a solitary kidney. (1999) (129)
Factors contributing to the declining mortality rate in renal transplantation. (1978) (129)
Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. (1998) (129)
Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. (1997) (127)
REVERSIBILITY OF CHRONIC RENAL ALLOGRAFT REJECTION: Critical Effect of Time After Transplantation Suggests Both Host Immune Dependent and Independent Phases of Progressive Injury1 (1994) (125)
The high cost of low-frequency events: the anatomy and economics of surgical mishaps. (1981) (125)
Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. (1995) (122)
Nephron supply is a major determinant of long-term renal allograft outcome in rats. (1994) (121)
Chronic graft rejection. (1994) (117)
Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. (1997) (116)
Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. (1997) (112)
Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats. (1986) (111)
Natural history of the leg amputee. (1977) (110)
PROGRESSIVE ALBUMINURIA AND GLOMERULOSCLEROSIS IN A RAT MODEL OF CHRONIC RENAL ALLOGRAFT REJECTION (1992) (110)
Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts. (1977) (106)
Small intestine transplantation in the rat--immunology and function. (1984) (106)
CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. (1997) (105)
Urologic complications in 718 renal transplant patients. (1984) (104)
The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. (1994) (103)
Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. (1998) (102)
The case for “presumed consent” in organ donation (1998) (102)
Sparing of suppressor cells: a critical action of cyclosporine. (1984) (102)
Liver disease in recipients of long-functioning renal allografts. (1985) (99)
Molecular and cellular events associated with ischemia/reperfusion injury. (2000) (96)
Mechanisms of chronic rejection. (2000) (96)
Renal Transplantation: A Twenty‐five Year Experience (1976) (90)
A model of gradual onset brain death for transplant-associated studies in rats. (2000) (87)
Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation. (1988) (87)
Adhesion Molecules and Transplantation (1994) (86)
Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. (1983) (84)
Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. (1995) (83)
SURFACE PROPERTIES AND FUNCTIONAL CHARACTERISTICS OF INFILTRATING CELLS HARVESTED FROM ACUTELY REJECTING CARDIAC ALLOGRAFTS IN INBRED RATS (1975) (83)
Brain death and its impact on the donor heart-lessons from animal models. (2000) (82)
Chronic allograft failure: the clinical problem. (1997) (82)
Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts. (1995) (75)
Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts. (1996) (71)
Renal mass as a determinant of late allograft outcome: insights from experimental studies in rats. (1995) (70)
Recognition of self within self: specific lymphocyte positioning and the extracellular matrix. (1991) (67)
Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation. (1997) (66)
A twenty year survey of arterial complications of renal transplantation. (1975) (63)
Transplantation biology : cellular and molecular aspects (1996) (62)
Chronic Thoracic Duct Fistula: Operative Technic and Physiologic Effects in Man (1968) (60)
CD4 monoclonal antibodies in organ transplantation--a review of progress. (1991) (60)
Mechanisms of Rejection and Prolongation of Vascularized Organ Allografts (1984) (59)
Suppressive effects of cyclosporin A on the induction of alloreactivity in vitro and in vivo. (1981) (59)
CYCLOSPORIN A SPARES SELECTIVELY LYMPHOCYTES WITH DONOR‐SPECIFIC SUPPRESSOR CHARACTERISTICS (1981) (58)
Changing clinical trends in patients with peripheral arterial emboli. (1976) (58)
Colonic perforations after renal transplantation. (1997) (57)
Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil. (1996) (57)
Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines. (2000) (57)
Transplant: From Myth to Reality (2003) (56)
Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand. (2002) (56)
Activation of proinflammatory genes in somatic organs as a consequence of brain death. (1999) (56)
CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE IN RENAL ALLOGRAFT RECIPIENTS (1984) (55)
Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. (1987) (55)
THE SENSITIZATION OF RATS BY ALLOGRAFTS TRANSPLANTED TO ALYMPHATIC PEDICLES OF SKIN (1971) (55)
Ischemia and reperfusion injury (2003) (53)
Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts. (1985) (53)
Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. (2002) (53)
Evidence for the presence of suppressor T lymphocytes in animals treated with cyclosporin A. (1982) (51)
Ultrasound in renal transplantation. (1977) (50)
Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model. (1998) (50)
Candesartan cilexetil reduces chronic renal allograft injury in Fisher → Lewis rats (1997) (48)
Chronic rejection: increasing evidence for the importance of allogen-independent factors. (1998) (48)
Renal Artery Stenosis in Transplant Patients (1984) (46)
The influence of donor brain death on short and long-term outcome of solid organ allografts. (2000) (46)
Infiltration patterns of macrophages and lymphocytes in chronically rejecting rat kidney allografts (1994) (44)
Rejected human renal allografts: recovery and characteristics of infiltrating cells and antibody. (1979) (44)
Hemorrhagic pancreatitis. A fatal complication of renal transplantation. (1966) (42)
The immunosuppressive effect of thoracic duct drainage in human kidney transplantation. (1970) (42)
Studies on infiltrating host cells harvested from acutely rejecting rat cardiac allografts. (1976) (42)
Experience with Cyclosporine and Steroids in Clinical Renal Transplantation (1984) (42)
Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms. (1990) (40)
Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance? (1984) (39)
Peripheral arterial complications of intra-aortic ballon counterpulsation. (1977) (38)
Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness: indefinite kidney allograft survival by treatment with a soluble P-selectin ligand and low-dose cyclosporine in combination. (1999) (36)
Early experience with anti-Tac in clinical renal transplantation. (1989) (35)
Should organs from patients in permanent vegetative state be used for transplantation? (1997) (35)
Management of general surgical complications following cardiac transplantation. (1989) (34)
Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. (1991) (34)
Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats. (1984) (34)
IMMUNE RESPONSES TO ORGAN ALLOGRAFTS: III. MARKED DECREASE IN MEDULLARY THYMOCYTES AND SPLENIC T LYMPHOCYTES AFTER CYCLOSPORIN A TREATMENT (1981) (33)
Cytokines and adhesion molecules in chronic rejection. (1994) (32)
Restoration of allograft responsiveness in B rats by interleukin 2 and/or adherent cells. (1982) (32)
Renal mass: An important determinant of late allograft outcome (1998) (31)
Transfer of specific unresponsiveness to organ allografts by thymocytes. Specific unresponsiveness by thymocyte transfer (1979) (30)
The biology of acute transplant rejection. (1991) (30)
The case for allowing kidney sales. International Forum for Transplant Ethics. (1998) (30)
T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates. (1976) (29)
The thoracic duct fistula as an adjunct to immunosuppression in human renal transplantation. (1967) (29)
Causes of peripheral embolism and their significance. (1966) (29)
Selective immunosuppression with anti‐interleukin 2 receptor‐targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts (1987) (29)
Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection. (1996) (29)
Femoral Triangle Sepsis in Dialysis Patients: Frequency, Management, and Outcome (1980) (28)
Acute rejection of rat renal allografts is accelerated by donor brain death. (1999) (27)
A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial. (1988) (27)
Immune and nonimmune mechanisms of chronic rejection of kidney allografts. (1995) (27)
DEVELOPMENT OF SUPPRESSOR LYMPHOCYTES DURING ACUTE REJECTION OF RAT CARDIAC ALLOGRAFTS AND PRESERVATION OF SUPPRESSION BY ANTI‐IL-2‐RECEPTOR MONOCLONAL ANTIBODY (1986) (27)
Lymphocyte Migration Patterns in Organ Allograft Recipients (1989) (26)
SPECIFICITY OF CELLULAR MIGRATION INTO CARDIAC ALLOGRAFTS IN RATS (1978) (26)
Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. (1991) (26)
Risk factors and outcomes of pancreatitis after open heart surgery. (2005) (25)
The detection of cardiac allograft rejection by alterations in proton NMR relaxation times. (1985) (25)
Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement. (1987) (24)
Renal transplantation between identical twins: A review (1986) (24)
Early cellular and molecular changes in ischemia/reperfusion injury: inhibition by a selectin antagonist, P-selectin glycoprotein ligand-1. (1997) (24)
Activation of proinflammatory mediators in heart transplants from brain-dead donors: evidence from a model of chronic rat cardiac allograft rejection. (2002) (23)
Selectin Blockade Plus Therapy with Low‐Dose Sirolimus and Cyclosporin A Prevent Brain Death‐Induced Renal Allograft Dysfunction (2005) (23)
Early and late inflammatory changes occurring in rat renal isografts from brain dead donors. (2001) (23)
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. (1991) (23)
Ischemia-reperfusion injury. (2001) (23)
Initial ischemia/reperfusion injury influences late functional and structural changes in the kidney. (1997) (23)
Late Mortality and Morbidity in Recipients of Long-Term Renal Allografts (1983) (23)
Augmenting kidney mass at transplantation abrogates chronic renal allograft injury in rats. (1996) (22)
Successful heterotopic heart transplantation in rat (1994) (22)
STUDIES ON ENHANCEMENT OF CARDIAC AND RENAL ALLOGRAFTS IN THE RAT (1974) (22)
Controlled clinical trial of antilymphocyte globulin in human renal allografts. (1971) (22)
The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts. (1990) (22)
THE EXTENT OF IMMUNOLOGICAL INJURY TO THE VASCULATURE OF CARDIAC ALLOGRAFTS IN THE RAT (1974) (21)
Host response to implanted dacron grafts. A comparison between mesh and velour. (1975) (21)
Prolongation of organ allograft survival by syngeneic lymphoid cells. (1978) (20)
Immune responses to organ allografts. I. Intense B-cell response to heart allografts in lymphoid tissues of unmodified rats. (1979) (20)
TNF as a mediator of cardiac transplant rejection, including effects on the intragraft protein C/protein S/thrombomodulin pathway. (1991) (20)
The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity. (1976) (19)
Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts. (1996) (19)
The potential use of cyclosporine in reconstructive surgery. (1985) (19)
Cytokines in the pathophysiology of acute and chronic allograft rejection (1996) (19)
Infection-associated macrophage activation accelerates chronic renal allograft rejection in rats. (1997) (19)
Unrelated living organ donation: ULTRA needs to go (2003) (19)
Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy. (1991) (18)
Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection. (1991) (18)
Non‐heartbeating kidney donors (1999) (18)
Insights into acute and chronic rejection. (1996) (18)
Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin. (1986) (17)
Organ transplantation from brain-dead donors: Its impact on short- and long-term outcome revisited* (2001) (17)
Immunoglobulin-secreting cells recovered from rejected human renal allografts. (1982) (17)
Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts (2004) (17)
Acute renal failure in surgical patients. Causes, clinical patterns, and care. (1983) (17)
Cerebromeningitis in immunosuppressed recipients of renal allografts. (1982) (17)
Chronic rejection and its risk factors. (1999) (17)
Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group. (1993) (17)
Serial analysis of cytokines, adhesion molecule expression, and humoral responses during development of chronic kidney allograft rejection in a new rat model. (1993) (17)
Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin. (1984) (17)
PHENOTYPE, ACTIVATION STATUS, AND SUPPRESSOR ACTIVITY OF HOST LYMPHOCYTES DURING ACUTE REJECTION AND AFTER CYCLOSPORINE‐INDUCED UNRESPONSIVENESS OF RAT CARDIAC ALLOGRAFTS (1985) (17)
Effects of mycophenolic acid mofetil on acute rejection of kidney allografts in rats. (1996) (17)
Donor brain death affects tempo and intensity of acute rejection of rat chronic allografts. (1999) (17)
Financial compensation for cadaver organ donation: good idea or anathema. (1993) (17)
Advances in the understanding of rejection mechanisms. (1989) (16)
Early risk factors contributing to the evolution of long-term allograft dysfunction (1997) (16)
Inhibition of the production of a soluble helper mediator by cyclosporin A results in the failure to generate alloreactive cytolytic cells in mixed-lymphocyte culture. (1983) (16)
Long-term results of cyclosporine treatment in renal transplantation. (1986) (16)
The influence of donor brain death on long-term function of renal allotransplants in rats. (2001) (16)
EFFECTS OF THYMECTOMY, THORACIC DUCT DRAINAGE, AND RADIATION ON T AND B LYMPHOCYTE DISTRIBUTION AND CARDIAC ALLOGRAFT SURVIVAL IN RATS (1981) (16)
Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody. (1989) (16)
The importance of lymphocyte migration patterns in experimental organ transplantation. (1985) (15)
Biology of vascularized organ allograft rejection in sensitized recipients (1990) (15)
Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells. (1989) (15)
Early events in acute allograft rejection: leukocyte/endothelial cell interactions (1993) (15)
RESTORATION OF ALLOGENEIC RESPONSIVENESS OF LYMPHOCYTES FROM CYCLOSPORIN A‐TREATED ANIMALS WITH INTERLEUKIN 2 (1982) (15)
The pathobiology of chronic rejection (1989) (15)
Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness. (1985) (15)
Transplantation and its biology: from fantasy to routine. (2000) (15)
Early and late injury to renal transplants from non-heart-beating donors. (2002) (15)
The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival. (1992) (15)
Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats. (1993) (14)
T cell activation antigens: therapeutic implications. (1987) (14)
Pharmacologic and immunologic agonists and antagonists of cyclosporine. (1988) (14)
Host leukocytes and their products in chronic kidney allograft rejection in rats (1994) (14)
Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts. (1987) (14)
Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects (1988) (14)
THE MIGRATION OF RAT LYMPHOID CELLS INTO SKIN GRAFTS: SOME SENSITISED CELLS LOCALISE PREFERENTIALLY IN SPECIFIC ALLOGRAFTS (1974) (13)
Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection. (1995) (13)
Five yearsʼ experience in renal transplantation with immunosuppressive drugs: Survival, function, complications and the role of lymphocyte depletion by thoracic duct fistula (1969) (13)
Treatment of Chronic Renal Failure by Transplantation and Disalysis: Two Decades of Cooperation (1975) (13)
Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts. (1989) (13)
W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts. (1987) (13)
Adhesion molecule interaction with extracellular matrix. (1993) (12)
Effect of RS61443 on chronic rejection of rat kidney allografts. (1995) (12)
Kallikrein excretion in renal transplant recipients and in uninephrectomized donors. (1985) (12)
Transplantation immunology: an introduction. (1994) (12)
Four patterns of human renal allograft rejection: a cytologic and in vitro analysis of the infiltrate in 24 irreversibly rejected kidneys. (1977) (12)
The different migratory characteristics of lymphocyte populations from a whole spleen transplant. (1975) (12)
Calyceal‐cutaneous Fistulae in Renal Transplant Patients (1976) (12)
Humoral and cellular mechanisms in acute allograft injury. (1987) (12)
Use of an ectopic pelvic donor kidney for transplantation. (1984) (12)
Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts. (1991) (12)
Modification of function and migration patterns of thymocyte populations by cyclosporine after organ transplantation in rats. (1984) (11)
Refined techniques for heterotopic cardiac transplantation in the rat. (1989) (11)
Infection-associated cellular activation accelerates chronic renal allograft rejection in rats (1996) (11)
The systemic distribution of soluble antigen injected into the footpad of the laboratory rat. (1970) (11)
Cyclosporine-induced transplantation unresponsiveness in rat cardiac allograft recipients: in vitro determination of helper and suppressor activity. (1985) (11)
Hemodialysis Access Part B — Permanent (1996) (11)
Anti-Ia antibody eluted from rejected human renal allografts. (1978) (11)
Variant forms of arteritis in human renal allografts. (1979) (11)
The cost of misadventures in colonic surgery. A model for the analysis of adverse outcomes in standard procedures. (1978) (11)
Recipient hypertension potentiates chronic functional and structural injury of rat renal allografts (2002) (10)
Monoclonal anti-T12 antibody as therapy for renal allograft rejection. (1983) (10)
Differential effects of interleukin 2 receptor-targeted therapy on heart and kidney allografts in rats. Depression of effectiveness of ART-18 monoclonal antibody treatment by uremia. (1990) (10)
Neutrophils and macrophages are prominent in the pathophysiology of chronic rejection of rat kidney allografts. (1993) (10)
MATURING THYMOCYTES IN ACCELERATED REJECTION OF CARDIAC ALLOGRAFTS IN PRESENSITIZED RATS (1992) (10)
Microangiography of the white pulp of the spleen. (1975) (10)
Reduction of ischemia/reperfusion injury in organ transplants by cytoprotective strategies (2001) (10)
A crisis in transplantation: Too much demand for too few organs (1998) (9)
Cells, cytokines, adhesion molecules, and humoral responses in a rat model of chronic renal allograft rejection. (1992) (9)
SYNERGY BETWEEN SUBTHERAPEUTIC DOSES OF CYCLOSPORINE AND IMMUNOBIOLOGICAL MANIPULATIONS IN RAT HEART GRAFT RECIPIENTS1 (1988) (9)
Influence of initial antigen-independent events on acute allograft rejection: inhibition by a soluble P-selectin ligand and low-dose cyclosporine in combination. (1998) (9)
Debate on financial incentives is off the mark of national and international realities. (2010) (9)
Early ischemic injury leads to long-term functional and morphologic deterioration of naive rat kidneys and may contribute to changes of chronic allograft rejection. (1994) (9)
The Skin Allograft Revisited: A Potentially Permanent Wound Coverage Option in the Critically Ill Patient (2009) (9)
Restoration of allograft responsiveness in B rats. II. Requirements for lymphoid populations and lymphokine. (1983) (9)
Migration patterns of lymphocytes from recipients of organ allografts. I. The unmodified host. (1981) (9)
Evidence for a beneficial effect of increased functional kidney mass upon chronic kidney rejection in rats. (1994) (9)
Influence of renal mass on chronic kidney allograft rejection in rats. (1995) (9)
Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation. (1989) (9)
EXPERIMENTAL GRAFT ARTERIOSCLEROSIS (1992) (8)
Identification, cytotoxicity, and suppressor activity of infiltrating cells from enhanced organ allografts. (1977) (8)
Systemic hypertension accelerates chronic rejection of renal allografts in the rat. (1999) (8)
Thoughts on the immunobiology of chronic allograft rejection. (1995) (8)
ENHANCEMENT OF CARDIAC ALLOGRAFTS IN RATS: COMPARISON OF HOST RESPONSES TO DIFFERENT TREATMENT PROTOCOLS (1978) (8)
Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital. (1985) (8)
Host-graft relationship: the systemic nature of allograft rejection. (1985) (8)
MIGRATION PATTERNS OF LYMPHOCYTES IN UNTREATED AND IMMUNOLOGICALLY MANIPULATED RECIPIENTS OF ORGAN ALLOGRAFTS (1982) (8)
Promotion of altruistic donation. (2009) (8)
In Memoriam: Charles Bernard Carpenter (2012) (8)
RENAL HYPOTHERMIA: IN VIVO TRANSAORTIC PERFUSION WITH RINGER'S LACTATE SOLUTION. (1965) (8)
Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat. (1985) (8)
Changes of chronic kidney allograft rejection are reversible after retransplantation. (1993) (7)
Anti-T12 monoclonal antibody therapy of acute renal allograft rejection. (1987) (7)
In vivo activity of mixed lymphocyte response-generated suppressor cells and ability to prolong cardiac allograft survival in rats. (1989) (7)
Transplant vasculopathy in rat heart transplantation: a morphologic chameleon determined by antigen-dependent and -independent factors. (1995) (7)
Inhibition of rat skin allograft rejection by cyclosporine. In situ characterization of the impaired local immune response. (1986) (7)
Deficiencies of IL-4 or TNF-alpha receptor-1 do not diminish graft arteriosclerosis in cardiac allografts. (1999) (7)
Interleukin 2 receptor--a target for immunosuppressive therapy. (1987) (7)
Surgical care of the patient with renal failure (1982) (7)
Mechanisms of cardiac allograft prolongation by cyclosporin-A. (1981) (7)
INFLUENCE OF SELECTIVE SPLENECTOMY ON SURVIVAL OF CARDIAC AND SKIN ALLOGRAFTS IN ENHANCED RATS (1980) (7)
EVIDENCE THAT THERAPEUTIC STRATEGIES TARGETED AT CD4+ CELLS MODULATE ACCELERATED REJECTION OF CARDIAC ALLOGRAFTS IN SENSITIZED RATS BY DIFFERENT MECHANISMS (1992) (7)
Vascular access for dialysis and cancer chemotherapy. (1986) (7)
SYNERGY BETWEEN CYCLOSPORINE AND ANTI‐IL-2 RECEPTOR MONOCLONAL ANTIBODIES IN RATS: FUNCTIONAL STUDIES OF HEART AND KIDNEY ALLOGRAFTS (1991) (7)
Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts. (1990) (6)
Ludwik Rydygier and the first gastrectomy for peptic ulcer. (1991) (6)
Differential effects of heterologous antisera on the survival of cardiac and skin allografts in rats. (1981) (6)
Immune responses to organ allografts. II. Decreased B cell responses to cardiac allografts in rats pretreated with enhancing, suppressor cell, or T lymphocyte depletion protocols. (1979) (6)
Stability of renal allograft recipients after conversion from cyclosporine to azathioprine. (1985) (6)
Invasion of the Body: Revolutions in Surgery (2011) (6)
Restoration of allograft responsiveness in B rats. IV. The divergent migratory behavior of lymphocyte populations mediating cardiac allograft rejection. (1984) (6)
Prompt treatment of initial acute rejection episodes may improve long‐term graft outcome (1998) (6)
Liver Disease in Recipients of Long-Functioning Renal Allografts (1986) (6)
Interleukin-2 Receptor Directed Immunosuppressive Therapy (1987) (6)
Antigen-independent events mimic characteristic changes of chronic allograft rejection. (1995) (6)
Correlation of macrophage and NK cell numbers with "activation markers" in rat cardiac allografts. (1989) (6)
The commercialization of transplantation. (2003) (6)
The role of leukocyte adhesion molecules in acute transplant rejection. (1994) (6)
Antibody-mediated rejection of organ grafts. (1989) (6)
Use of living donors in renal transplantation. (1987) (6)
Intragraft immune events causing vascularized organ graft rejection. (1978) (6)
Systemic natural killer activity following cardiac engraftment in the rat: lack of correlation with graft survival. (1986) (5)
ENHANCED ALLOGRAFT SURVIVAL BY COMBINED ACTIVE AND PASSIVE IMMUNIZATION: REQUIREMENT OF BOTH ERYTHROCYTES AND LEUKOCYTES (1978) (5)
A characterization of the nature and control of cellular allograft rejection. (1978) (5)
A Perfectly Striking Departure: Surgeons and Surgery at the Peter Bent Brigham Hospital, 1912—1980 (2006) (5)
Harvey Cushing and the evolution of a polymath. (1986) (5)
The relationship between reduced functioning kidney mass and chronic rejection in rats (1994) (5)
THE EFFECT OF NEONATAL THYMECTOMY IN THE DOG. (1965) (5)
Hemorrhagic pancreatitis: a fatal complication of renal transplantation (1967) (5)
Altered alloimmune response toward grafts from brain-dead donors in chronic rat cardiac allograft rejection. (2001) (5)
Inflammatory mediators, cells and their products in acute host alloresponsiveness. (1996) (5)
Host sensitization by alymphatic skin allografts in the rat. (1970) (5)
RESTORATION OF ALLOGRAFT RESPONSIVENESS IN B RATS (1983) (5)
Nonimmune factors may contribute to chronic rejection of kidney transplants. (1994) (5)
Studies on mechanisms of acute rejection of vascularized organ allografts. (1986) (5)
Rehabilitation profile of kidney transplant patients. (1978) (5)
Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network. (1989) (4)
Prompt treatment of initial acute rejection episodes may improve long-term graft outcome (1998) (4)
An effective technique for management of transplant kidneys with polar branches. (1976) (4)
Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat. (1987) (4)
The role of the B 7 costimulatory pathway in experimental cold ischemia / reperfusion injury (2013) (4)
Conservative management of the failed renal allograft: indications for transplant nephrectomy. (1982) (4)
Characteristic signs of chronic allograft rejection can be observed in mechanically manipulated naive rat kidneys over the long-term. (1995) (4)
Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype. (1988) (4)
Microangiopathic hemolytic anemia associated with hyperacute rejection of a kidney allograft. (1982) (4)
SYNERGY BETWEEN SUBTHERAPEUTIC DOSES OF CYCLOSPORINE AND IMMUNOLOGIC ENHANCEMENT IN RAT RECIPIENTS OF CARDIAC ALLOGRAFTS1 (1988) (4)
Transfer of specific unresponsiveness to organ allografts by thymocytes. (1999) (4)
Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection. (1997) (4)
Late development of intractable lymphocele after renal transplantation. (1988) (4)
Accelerated graft dysfunction in renal isografts from non-heart-beating donors. (2001) (4)
Platelet-induced donor-specific unresponsiveness to kidney allografts in mongrel dogs treated with ALG. (1981) (4)
Improvements in early behaviour of kidney allografts after donor treatment. (2002) (4)
Leg trauma with posterior tibial artery tear. (1967) (4)
Suppression of renal allograft rejection by low density thymocytes. (1981) (3)
Early inflammatory events associated with chronic allograft rejection (1999) (3)
Migration patterns of lymphocytes from recipients of organ allografts. II. The enhanced host. (1983) (3)
The use of percutaneous nephrostomy in patients with ureteric obstruction undergoing renal transplantation. (1986) (3)
Host cell proliferation in response to skin allografts on alymphatic pedicles. (1974) (3)
Binding of lymphocytes to acutely rejecting rat kidney allografts in vitro is guided by events in the graft itself rather than by sensitization of host lymphocytes. (1995) (3)
Current stage of interleukin 2 receptor targeted therapy. (2009) (3)
Infection‐associated cellular activation accelerates chronic renal allograft rejection in rats (1996) (3)
Prevention of chronic rejection of renal allografts in rats using a synthetic inhibitor of macrophage effector activation. (1995) (3)
Renal transplantation. (1989) (3)
Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy. (1981) (3)
Changes in lymphocyte migration patterns after heart grafting in rats. (1981) (3)
Angioaccess in the Renal Failure Patient (1989) (3)
Treatment with anti-interleukin-2 receptor monoclonal antibody. (1986) (3)
Triumph of hope over experience. (2000) (3)
A statement from the transplantation society against organ trafficking and commerce in organs. (2008) (3)
Hepatic abscess produced by extension of a perinephric abscess. (1972) (3)
T suppressor lymphocytes reverse ongoing acute allograft rejection. (1985) (3)
EVIDENCE THAT MONOCLONAL ANTIBODIES AGAINST THE 55kD SUBUNIT OF THE RAT IL‐2 RECEPTOR DO NOT INHIBIT THE DEVELOPMENT OF SUPPRESSOR CELLS GENERATED IN MIXED LYMPHOCYTE CULTURE (1990) (3)
Immune responsiveness following skin grafting in cyclosporine-treated rats. (1987) (3)
The new chimaera: the industrialization of organ transplantation. International Forum for Transplant Ethics. (2001) (3)
The capacity of lymphocytes from recipients of acutely rejecting allografts to modulate macrophage plasminogen activator activity. (1981) (3)
The character of effector cells and the accumulation of macrophages in rejecting heart allografts in the rat. (1973) (3)
Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18. (1988) (3)
Selective localization of cortical thymocytes to cardiac allografts in enhanced rats. (1982) (3)
Morphological changes in indefinitely surviving enhanced ectopic rat cardiac allografts (1976) (2)
H. Myron Kauffman, Jr., M.D., FACS (2007) (2)
ACCELERATED RATE OF ACUTE REJECTION OF RENAL ALLOGRAFTS FROM BRAIN DEAD DONORS. (1998) (2)
Interleukin 2 Receptor Targeted Immunotherapy — Update and Attempt at Synthesis (1989) (2)
OCCLUSION OF THE SUPERIOR VENA CAVA BY A PERICARDIAL BAND: REPORT OF A CASE. (1964) (2)
In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic. (1989) (2)
The accumulation of gallium-67-labeled leukocytes in rat cardiac allografts. (1976) (2)
Harvey Cushing and the surgical research laboratory. (1980) (2)
Aqueous Silver Nitrate (0.5%) in the Treatment of Nonthermal War Wounds (1969) (2)
NEW MODEL OF COLD ISCHEMIA/REPERFUSION INJURY: CCR1 KNOCKOUT MICE ARE PROTECTED AGAINST RENAL INJURY. (1999) (2)
Successful management of catastrophic intraabdominal complications following cardiac transplantation. (1989) (2)
Immunohistologic profile of cells infiltrating acutely rejecting and long-surviving rat cardiac allografts. (1988) (2)
Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A. (1988) (2)
Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival. (1992) (2)
Pathophysiology of Brain Death in Small Animal Models (2013) (2)
DONOR BRAIN DEATH ACCELERATES PROGRESSIVE DYSFUNCTION OF LONG SURVIVING RAT RENAL ALLO‐AND ISOGRAFTS.: Abstract# 915 Poster Board #‐Session: P172‐III (2000) (2)
Suppressor cells influence maintenance and reversal of late rejection in indefinitely surviving skin allografts in cyclosporine-treated rats. (1988) (2)
Host response to cardiac allografts in rats. Effect of thymectomy, irradiation, T cell depletion, or AgB compatibility. (1976) (2)
Prolongation of survival and preservation of allograft structure and function by a signaling CD28 mAB in a rat model of chronic kidney rejection. (2001) (2)
Donor hypertension and recipient immune responsiveness in chronic rat cardiac allograft rejection. (2001) (1)
Introduction of Pekka Häyry (2006) (1)
URINARY CYTOKINE PATTERNS IN RENAL ALLOGRAFT RECIPIENTS (1998) (1)
Synergistic immunosuppressive effect of subtherapeutic doses of cyclosporine A on immunologic enhancement in rat recipients of cardiac allografts. (1988) (1)
Harvey Cushing and the Oxford connection. (1982) (1)
W3/25+ T cells mediate specific unresponsiveness in enhanced allograft recipients. (1987) (1)
HYPERTENSION INDUCES TRANSPLANT ARTERIOSCLEROSIS IN RAT RENAL ALLOGRAFTS VIA ENDOTHELIN AND CHEMOKINE RECEPTOR INDUCTION BY VASCULAR SMOOTH MUSCLE CELLS. (1999) (1)
Acute lead neuropathy: tracheo-innominate fistula. (1975) (1)
PRESENCE OF SPLENIC SUPPRESSOR CELLS IN ALLOGRAFT ENHANCED RATS (1977) (1)
ACCELERATED GRAFT DYSFUNCTION IN RENAL ISOGRAFTS FROM NON HEART‐BEATING DONORS.: Abstract# 347 Poster Board #‐Session: P194‐I (2000) (1)
55 – Animal Models in Transplantation (2001) (1)
Severe temporary deterioration of renal transplant function following meningococcemia. (1971) (1)
T cells and their products in host responsiveness to organ allografts. (1986) (1)
Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts. (1990) (1)
The antigenicity of electrocauterized allogeneic tumor cells in mice. (1982) (1)
Human renal kallikrein-kinin system after engraftment and/or immunosuppression. (1989) (1)
Harvey Cushing and his books. (1989) (1)
Recent Advances in Renal Transplantation (1981) (1)
Proceedings: Nature of cells removed from rejecting rat cardiac allografts;. (1975) (1)
Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts. (1991) (1)
The treatment of chronic renal failure by transplantation. (1977) (1)
Kidney transplantation in the treatment of terminal uremia. (1981) (1)
Interleukin-2 Receptor Targeted Immunosuppressive Therapy with Anti-Interleukin-2 Receptor Monoclonal Antibodies Directed against the L-Chain of the Interleukin-2 Receptor: Studies on Selectivity and Mode of Action (1989) (1)
The marrow of the tragedy (Harvey Cushing). (1983) (1)
PROLONGED SURVIVAL OF ALYMPHATIC SKIN ALLOGRAFTS IN THE RAT A HUMORAL COMPONENT (1978) (1)
Cushing, Cutler and the mitral valve. (1981) (1)
Populations of infiltrating cells removed from rejecting rat cardiac allografts. (1974) (1)
Suppressor cells in enhancement of organ allografts. (1979) (1)
A year's fellowship in America. (1977) (1)
Prevention of chronic rejection and puromycin-induced glomerulosclerosis in rats by gamma-lactone, an inhibitor of macrophage-effector activation. (1996) (1)
Cell Mediated and Humoral Immunity in a Rat Experimental Cirrhosis Model (1976) (1)
Early and late injury to renal transplants from non–heart-beating donors1 (2002) (1)
11. Shifting Foundations (2011) (0)
Host-graft relationship in accelerated rejection of rat cardiac allografts. (1989) (0)
Brain-Death – Related Early Changes and Late Outcome after Kidney Transplantation Beneficial Effects of Recombinant Soluble P-Selectin Glycoprotein Ligand ( rPSGL-Ig ) on Donor (2002) (0)
The technique of transsternal thymectomy in the puppy. (1969) (0)
INITIAL SELECTIN BLOCKADE OF T CELL ACTIVATION AND SIGNALLING COMBINED WITH LOW-DOSE SIROLIMUS AND CYCLOSPORINE IMMUNOSUPPRESSION PREVENTS CHRONIC REJECTION OF KIDNEY ALLOGRAFTS (2004) (0)
Progress in Transplantation (1984) (0)
[Cyclosporin A--a new immunosuppressive drug]. (1984) (0)
Synergistic effects of ATS and passive and active enhancement on heart and skin allografts in rats. (1983) (0)
The Divine Relativity (2017) (0)
Tissue Transplantation—Clinical Surgery International—Volume 3 (1983) (0)
Mechanisms of cardiac allo graft prolongation by cyclosporin a (1980) (0)
Book Review The Puzzle People: Memoirs of a Transplant Surgeon By Thomas E. Starzl. 364 pp., illustrated. Pittsburgh, University of Pittsburgh Press, 1992. $24.95. 0-8229-3714-X (1993) (0)
Modified immune responses of T-cell-depleted rats to vascularly anastomosed organ grafts. (1978) (0)
Kallikrein Excretion in Renal Transplant Recipients and in Uninephrectomized Donors (1986) (0)
DONOR BRAIN DEATH INTENSIFIES REPERFUSION INJURY AFTER ALLOGENEIC KIDNEY TRANSPLANTATION (1999) (0)
Introduction of the 2010 recipient of the Medawar Prize of The Transplantation Society: Professor Clyde Barker. (2010) (0)
7. Operations on the Heart (2011) (0)
Erratum: Promotion of altruistic donation (Transplantation (2009) (847)) (2009) (0)
Organ transplantation – a brief history (2009) (0)
Thoracic duct fistula in human being renal transplantation. (1966) (0)
Aqueous silver nitrate (0.5 percent) in the treatment of nonthermal war wounds. (1969) (0)
The Impact of Donor Brain Death on Graft Integrity after Transplantation: Insights from Chronic Rat Cardiac Allograft Rejection (2002) (0)
[Targeted immunotherapy against interleukin 2 receptors (IL-2R)--an attempt at synthesis]. (1992) (0)
Mycotic aneurysm from unrecognised colonic sepsis. (1977) (0)
DONOR AND RECIPIENT AGE ARE INDEPENDENT DETERMINANTS FOR ACUTE REJECTION RATES AND TRANSPLANT OUTCOME: 1354 (2010) (0)
Personal View (1973) (0)
Beneficial Effects of Recombinant Soluble P-Selectin Glycoprotein Ligand (rPSGL-Ig) on Donor Brain-Death-Related Early Changes and Late Outcome after Kidney Transplantation (2002) (0)
Acceleration of Chronic Rejection of Kidney Allografts from Non-Heartbeating Donors (2002) (0)
Carl Walter and the evolution of the Surgical Research Laboratory: 1937 through 1949. (1984) (0)
Transplantation--challenges for the future may be more philosophical than biological. (1994) (0)
The Impact of Donor Hypertension on Intragraft Changes in Chronic Rat Cardiac Allograft Rejection (2002) (0)
[Immunosuppressive therapy in transplantation surgery]. (2008) (0)
Curriculum vitae of John P. Merrill (1978) (0)
Patterns of thymocyte migration in unmodified and enhanced recipients of cardiac allografts. (1979) (0)
Introduction of the President of The Transplantation Society, Jeremy Chapman, 2008-2010. (2010) (0)
The Transplantation Society: a global presence. (2008) (0)
A broadening of vision: observation on the practice of surgery in a university hospital in Great Britain. (1974) (0)
Book ReviewRenal Transplantation (1984) (0)
A SIGNALING CD28 ANTIBODY PROLONGS SURVIVAL AND PRESERVES RENAL ALLOGRAFT STRUCTURE AND FUNCTION IN A RAT MODEL OF CHRONIC REJECTION.: Abstract# 1169 (2000) (0)
The effect of T-cell depletion on host responses to organ allografts. (1979) (0)
Proceedings: passive enhancement of heterotopic rat heart transplants. (1973) (0)
Induction of alloreactivity. (1983) (0)
Increased survival of vascularized organ allografts in the rat has been achieved by active host immunization with donor antigen, passive immunization with alloantise- (2003) (0)
In support of having your operation where there is training of surgical residents. (1981) (0)
Symposium: update on nutrition. (1990) (0)
Book ReviewThe Twilight Years of Lady Osler: Letters of a doctor's wife (1985) (0)
Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo. (1989) (0)
Syngeneic Lymphoic Cells Prolongation of Organ Allograft Survival by (2012) (0)
Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats. (1991) (0)
12. Unsolved Challenges (2011) (0)
Book ReviewRenal Function in Anaesthesia and Surgery (1980) (0)
Reversal of allograft rejection. (1994) (0)
BRAIN DEATH ENHANCES INJURY OF RAT CARDIAC ALLOGRAFTS BY INDUCTION OF MULTIPLE CHEMOKINES, CHEMOKINE RECEPTORS AND PROINFLAMMATORY MEDIATORS (1999) (0)
routineand its biology: from fantasy to (2015) (0)
Impact of donor brain death on tempo and intensity of acute rejection of rat cardiac allografts (1999) (0)
A humoral component in prolongation of alymphatic skin allografts in rats. (1976) (0)
DONOR BRAIN DEATH AS A RISK FACTOR FOR CHRONIC REJECTION OF RAT CARDIAC ALLOGRAFTS.: Abstract# 916 Poster Board #‐Session: P173‐III (2000) (0)
Book ReviewThe Chief: Doctor William Osler (1984) (0)
Donor brain death intensifies the recipient inflammatory response in chronic rat cardiac allograft rejection (2002) (0)
[Cyclosporin: experimental studies and clinical use in organ transplants]. (1984) (0)
Acute host responses to organ allografts (1986) (0)
Books in brief (2011) (0)
ERYTHRASMA; ITS POSSIBLE RELATION TO RED FLUORESCENCE IN SQUAMOUS CELL CARCINOMA. (1963) (0)
Alan G. Birtch (february 3, 1932 to December 28, 2011): Early Transplantation Pioneer (2012) (0)
BOOK REVIEW Transplant From Myth to Reality (2005) (0)
Cardiac Allograft Rejection The Impact of Donor Brain Death on Graft Integrity after Transplantation : Insights from Chronic Rat (2002) (0)
INFLUENCE OF DONOR BRAIN DEATH ON ACUTE REJECTION OF RAT CARDIAC ALLOGRAFTS (1998) (0)
The original Peter Bent Brigham Hospital surgical staff. (1981) (0)
9. The Transfer of Organs (2011) (0)
6. The Promise of Surgical Research (2011) (0)
1. Three Operations (2011) (0)
2. The Teaching Hospital (2011) (0)
Studies on living cells harvested from acutely rejecting and enhanced rat cardiac allografts. (1975) (0)
4. Steps Forward and Steps Backward (2011) (0)
8. The Mechanical Heart (2011) (0)
Kidney Transplantation: Principles and Practice (5th Edition) Edited by Peter J. Morris, PhD, FRCS 787pp, $199. ISBN 0-7216-8297-9. (2001) (0)
Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts. (1991) (0)
Dissolution of allograft collecting system following hemorrhagic pancreatitis. (1982) (0)
3. Evolution of a Profession (2011) (0)
Prolonged allograft survival following cell transfusions. (1977) (0)
Invited commentary (2005) (0)
[The first successful transplantation of the kidney--already a part of the history of medicine]. (1985) (0)
Suppression of lymph node CTL generation by spleen cells from cyclosporine-treated cardiac-allografted rats. (1987) (0)
5. War and Peace (2011) (0)
10. Making a Surgeon, Then and Now (2011) (0)
NEONATAL THYMECTOMY IN THE DOG. (1964) (0)
Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation. (1987) (0)
Prolongation of skin allografts following transplantation of intact sensitized spleens. (1977) (0)

This paper list is powered by the following services:

Nicholas L. Tilney's Academic­Influence.com Rankings

Nicholas L. Tilney's Degrees

Why Is Nicholas L. Tilney Influential?

Nicholas L. Tilney's Published Works

Published Works

Nicholas L. Tilney's AcademicInfluence.com Rankings